Abvc Biopharma Income Statement (2010-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Shares Outstanding (Entity) (Quarter)	2.79M	2.89M	3.03M	3.23M	3.26M	3.29M	3.31M	3.31M	4.82M	4.34M	10.70M	12.05M	12.71M	13.87M	15.38M	19.53M	24.19M	20.11M	25.77M	26.65M
Revenue & cost
Revenue (Quarter)	0.10M	-0.39M	0.03M	0.31M	0.04M	0.59M	0.13M	0.01M	0.02M	0.00M	0.00M	0.12M	0.39M	0.00M				-0.76M
Gross Profit (Quarter)	0.10M	-0.04M	0.02M	0.30M	0.03M	0.32M	0.07M	-0.07M	-0.01M	-0.14M	928.00	0.12M	0.39M	0.00M			0.80M	0.83M
Operating items
Research & Development (Quarter)	0.26M	0.26M	0.36M	0.53M	0.31M	1.50M	0.33M	0.51M	0.14M	0.07M	0.07M	0.04M	0.04M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.02M
Wages, Salaries and Other (Quarter)
Selling, General & Administrative (Quarter)	1.58M	1.77M	1.19M	1.59M	3.22M	0.07M	1.27M	1.39M	1.18M	1.53M	0.74M	0.65M	0.56M	0.31M	0.62M	0.69M	0.80M	0.78M	0.75M	0.50M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)	0.23M	4.38M	0.04M	0.23M	0.23M	1.89M	0.37M	0.23M	0.82M	-1.22M	2.03M	0.28M	0.10M	0.36M	0.05M	1.57M	1.14M	1.39M	0.79M	0.25M
Operating Expenses (Quarter)	2.07M	6.41M	6.24M	2.35M	3.75M	3.46M	1.97M	2.13M	2.14M	0.37M	2.84M	0.98M	0.69M	0.71M	0.69M	2.29M	1.96M	2.20M	1.57M	0.78M
Operating Income (Quarter)	-1.97M	-6.45M	-6.22M	-2.05M	-3.72M	-3.13M	-1.91M	-2.19M	-2.15M	-0.51M	-2.84M	-0.86M	-0.30M	-0.70M	-0.69M	-2.29M	-1.96M	-2.20M	-1.57M	-0.78M
EBIT (Quarter)	-1.97M	-6.45M	-6.22M	-2.05M	-3.72M	-3.13M	-1.91M	-2.19M	-2.15M	-0.51M	-2.84M	-0.86M	-0.30M	-0.70M	-0.69M	-2.29M	-1.96M	-2.20M	-1.57M	-0.78M
Non-operating items
Non Operating Investment Income (Quarter)												-0.08M			-0.05M				-0.03M	-0.02M
Interest & Investment Income (Quarter)	0.01M	-0.03M	0.04M	0.04M	0.05M	0.06M	0.05M	0.06M	0.04M	0.04M	0.00M	0.03M	0.04M	0.01M	0.02M	0.02M	0.05M	0.08M	0.00M	683.00
Other Non Operating Income (Quarter)	0.01M	0.49M	0.04M	0.02M	-177.00	-0.26M	0.00M	0.00M	-0.03M	0.08M	0.02M	-0.06M	-0.01M	0.11M	0.01M	0.14M	-0.11M	-0.09M	-0.05M	0.01M
Non Operating Income (Quarter)	0.01M	0.56M	-0.01M				0.01M	-0.04M	-1.21M	-0.01M	-0.09M	-0.30M	-0.18M	-0.09M	-0.25M	-0.01M	-0.12M	-0.82M	-0.12M	-0.03M
Net income details
EBT (Quarter)	-1.96M	-5.89M	-6.17M	-2.03M	-3.77M	-3.54M	-1.90M	-2.23M	-3.37M	-0.52M	-2.93M	-1.16M	-0.49M	-0.80M	-0.94M	-2.31M	-2.08M	-3.02M	-1.69M	-0.81M
Tax Provisions (Quarter)	-0.08M	1.01M	-0.09M	-0.08M	0.00M	0.80M		0.08M	-999.00	0.18M		-0.11M	355.00		-0.20M	0.02M	527.00		-0.35M	-0.17M
Profit After Tax (Quarter)	-1.89M	-7.55M	-6.09M	-1.95M	-3.89M	-4.63M	-1.82M	-2.32M	-3.33M	-0.21M	-2.88M	-0.94M	-0.37M	-0.80M	-0.94M	-2.33M	-2.04M	-2.73M	-1.56M	-0.81M
Equity Income (Quarter)	-0.09M	-0.08M
Income from Non-Controlling Interests (Quarter)	-0.08M	1.03M	-0.09M	-0.09M	-0.07M	0.36M	-0.07M	0.03M	-0.05M	-0.32M	-0.09M	-0.11M	0.24M	0.01M	0.01M	-0.08M	0.03M	-0.25M	-0.13M	-0.07M
Income from Continuing Operations (Quarter)	-1.89M	-6.90M	-6.09M	-1.95M	-3.78M	-4.33M	-1.90M	-2.32M	-3.37M	-0.70M	-2.93M	-1.05M	-0.49M	-0.80M	-0.75M	-2.33M	-2.08M	-3.02M	-1.34M	-0.64M
Consolidated Net Income (Quarter)	-1.89M	-6.90M	-6.09M	-1.95M	-3.78M	-4.33M	-1.90M	-2.32M	-3.37M	-0.70M	-2.93M	-1.05M	-0.49M	-0.80M	-0.75M	-2.33M	-2.08M	-3.02M	-1.34M	-0.64M
Income towards Parent Company (Quarter)	-1.81M	-7.93M	-6.00M	-1.95M	-3.78M	-4.33M	-1.90M	-2.32M	-3.37M	-0.70M	-2.93M	-1.05M	-0.49M	-0.80M	-0.75M	-2.33M	-2.08M	-3.02M	-1.34M	-0.64M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-1.81M	-7.93M	-6.00M	-1.86M	-3.70M	-0.56M	-1.82M	-2.26M	-3.32M	6.21M	-2.93M	-1.01M	-0.19M	10.39M	0.94M	-2.33M	-2.08M	-3.02M	-1.34M	-0.64M
Additional items
EPS (Basic) (Quarter)	-0.67	-3.17	-2.02	-0.59	-1.14	-0.18	-0.55	-0.68	-0.82	1.43	-0.30	-0.09	-0.02	0.89	0.06	-0.13	-0.09	-0.15	-0.05	-0.03
EPS (Diluted) (Quarter)	-0.67	-3.17	-2.02	-0.59	-1.14	-0.18	-0.55	-0.68	-0.82	1.43	-0.30	-0.09	-0.02	0.89	0.06	-0.13	-0.09	-0.15	-0.05	-0.03
Shares Outstanding (Quarter)	2.69M	2.51M	2.97M	3.13M	3.26M	3.17M	3.31M	3.31M	4.06M	4.34M	9.74M	11.32M	12.41M	11.67M	14.97M	17.39M	23.26M	20.11M	25.45M	25.45M
Shares Outstanding (Diluted) (Quarter)	2.69M	2.51M	2.97M	3.13M	3.26M	3.02M	3.31M	3.31M	4.06M	4.34M	9.74M	11.32M	12.41M	11.67M	14.97M	17.39M	23.26M	20.11M	25.45M	25.45M
EBITDA (Quarter)	-1.97M	-6.45M	-6.22M	-2.05M	-3.72M	-3.13M	-1.91M	-2.19M	-2.15M	-0.51M	-2.84M	-0.86M	-0.30M	-0.70M	-0.69M	-2.29M	-1.96M	-2.20M	-1.57M	-0.78M
Interest Expenses (Quarter)	0.02M	0.01M	0.04M	0.01M	0.65M	0.13M	7.58M	6.35M	6.36M	-1.36M	6.25M	6.24M	0.65M	0.80M	6.58M	6.76M	0.28M	0.34M	2.17M	7.70M
Tax Rate (Quarter)	3.86	-17.17	1.41	4.06	-0.11	-22.50		-3.66	0.03	-33.39		9.57	-0.07		20.98	-1.02	-0.03		21.00	21.00

Research Tools

Datasets

Plans

Developers

Abvc Biopharma ABVC Income Statement (2010-2026)

Research Tools

Datasets

Plans

Developers

Abvc Biopharma ABVC Income Statement (2010-2026)

Create an account

Sign In

Reset Password